Source link : https://www.newshealth.biz/health-news/fda-oks-once-nightly-lumryz-for-children-with-narcolepsy/
The US Food and Drug Administration (FDA) has approved Avadel Pharmaceuticals’ supplemental new drug application for extended-release sodium oxybate (Lumryz) for treatment of cataplexy or excessive daytime sleepiness in children 7 years of age and older with narcolepsy. The FDA first approved the once-nightly formulation of sodium oxybate for treatment of cataplexy or excessive daytime […]
Author : News Health
Publish date : 2024-10-17 18:15:22
Copyright for syndicated content belongs to the linked Source.
Categories